QUANTRX BIOMEDICAL CORPORATION — Net Income by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/d1e11be8-01c6-4035-9909-d82e9023039a/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $-260.0k | 2021-01-01 – 2021-12-31 | evidence 0001493152-22-010071 |
| FY 2020 | $-252.7k | 2020-01-01 – 2020-12-31 | evidence 0001654954-21-004257 |
| FY 2019 | $-621.9k | 2019-01-01 – 2019-12-31 | evidence 0001654954-20-004054 |
| FY 2018 | $-736.9k | 2018-01-01 – 2018-12-31 | evidence 0001654954-19-004468 |
| FY 2017 | $869.1k | 2017-01-01 – 2017-12-31 | evidence 0001654954-18-004035 |
| FY 2016 | $-398.0k | 2016-01-01 – 2016-12-31 | evidence 0001654954-17-003379 |
| FY 2015 | $-467.8k | 2015-01-01 – 2015-12-31 | evidence 0001415889-16-005518 |
| FY 2014 | $-827.0k | 2014-01-01 – 2014-12-31 | evidence 0001415889-15-001361 |
| FY 2013 | $-358.3k | 2013-01-01 – 2013-12-31 | evidence 0001415889-14-001167 |
| FY 2012 | $-718.0k | 2012-01-01 – 2012-12-31 | evidence 0001415889-13-000747 |
| FY 2011 | $-783.6k | 2011-01-01 – 2011-12-31 | evidence 0001415889-12-000555 |
| FY 2010 | $831.2k | 2010-01-01 – 2010-12-31 | evidence 0001415889-12-000555 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
QUANTRX BIOMEDICAL CORPORATION — all facts · Revenue · Operating Income